6505--Allopurinol Tablets

The solicitation requires offerors to submit a federally‑mandated subcontracting plan that meets the goals for small business participation—including small business, veteran‑owned, service‑disabled veteran‑owned, HUBZone, small disadvantaged, and women‑owned firms—expressed as dollar amounts and percentages for the base period and any option years. Commercial plans must incorporate all indirect costs, while individual plans must detail the method for allocating indirect costs to each small‑business category. Offerors must provide a currently approved commercial plan or a new plan for approval, complete the FAR representations and certifications (including FAR 52.209‑7, 52.219‑1, 52.204‑24, 52.225‑6, and 52.212‑3) via SAM.gov, and flow down the small‑business utilization clause (52.219‑8) to all subcontracts exceeding the FAR 19.702(a) threshold. In addition, all proposed drug products/NDCs must be listed on the offeror’s FSS contract or interim agreement with an established Permanent FCP by the offer deadline; non‑compliant offers will be rejected. Contractors must submit quarterly sales reports reporting contract sales in whole dollars and remit cost‑recovery fees as required. Prices must be firm for 120 calendar days unless otherwise specified, and product samples, when required, must be provided at no cost to the Government and returned at the offeror’s expense unless destroyed during testing.

Notice ID

1380a731a7b448eb940b80bc24dae3fe

Solicitation Number

36E79725R0067

NAICS Code

325412

Classification Code

6505